Dr. Reddy's Laboratories’ arm enters into agreement to sell certain assets, liabilities

19 Dec 2022 Evaluate

Dr. Reddy's Laboratories’ wholly owned subsidiary -- Dr. Reddy's Research and Development B. V. has entered into an asset purchase agreement for sale of its certain assets and liabilities including transfer of employees at site situated at Zernikedreef 12, 2333, CL Leiden, The Netherlands. Dr. Reddy's Research and Development B. V. has entered into an asset purchase agreement with Delpharm Development Leiden BV, part of France-based Delpharm Group.

The agreed consideration for the assets and liabilities of the said site is Euro 1. Further the company has agreed to pay to the purchaser a compensation of Euro 11.35 million for certain operating expenses related to the site. The compensation would be increased by an amount of Euro 1,50,000 upon satisfaction of certain conditions. Post this, no further payment would be made to the purchaser. It expects the deal to conclude by December 31, 2022.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1275.05 -1.95 (-0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×